Bill Texts: US HB2276 | 2011-2012 | 112th Congress

Bill Title: To require the Director of the United States Patent and Trademark Office to conduct a study on effective ways to provide confirming genetic diagnostic test activity where gene patents and exclusive licensing exist, and for other purposes.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2011-08-25 - Referred to the Subcommittee on Intellectual Property, Competition and the Internet. [HB2276 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2011-06-24PDFLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for US Congress HB2276

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for US Congress HB2276 currently on file.

Social Comments on US HB2276

feedback